A new era in therapeutics for diabetic kidney disease

被引：5
|
作者：
Wanner, Christoph [1 ]
机构：
[1] Wurzburg Univ Hosp, Div Nephrol, Dept Med, Oberdurrbacherstr 6, D-97080 Wurzburg, Germany
来源：
NATURE REVIEWS NEPHROLOGY | 2018年 / 14卷 / 02期
关键词：
TYPE-2; EMPAGLIFLOZIN; OUTCOMES;
D O I：
10.1038/nrneph.2017.182
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
2017 saw the emergence of a new era in renoprotective medicine for diabetic kidney disease with reports of promising renal outcomes with the sodium-glucose cotransporter 2 (SGLT2) inhibitors empagliflozin and canagliflozin from follow-up analyses of the EMPA-REG OUTCOME trial and the CANVAS Program, respectively, and with use of the glucagon-like peptide 1 (GLP1) agonist liraglutide in the LEADER trial.
引用
收藏
页码：78 / +
页数：2
相关论文
共 50 条
  • [1] A new era in therapeutics for diabetic kidney disease
    Christoph Wanner
    [J]. Nature Reviews Nephrology, 2018, 14 : 78 - 80
  • [2] Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection
    Mazzieri, Alessio
    Porcellati, Francesca
    Timio, Francesca
    Reboldi, Gianpaolo
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (07)
  • [3] Diabetic kidney disease: the onset of a new era?
    Fioretto, Paola
    [J]. JOURNAL OF NEPHROLOGY, 2020, 33 (05) : 899 - 900
  • [4] Diabetic kidney disease: the onset of a new era?
    Paola Fioretto
    [J]. Journal of Nephrology, 2020, 33 : 899 - 900
  • [5] A New Therapeutic Era in the Management of Diabetic Kidney Disease
    Rosas, Sylvia E.
    Cherney, David Z. I.
    [J]. ADVANCES IN CHRONIC KIDNEY DISEASE, 2021, 28 (04) : 280 - 281
  • [6] Diabetic kidney disease: from physiology to therapeutics
    Mora-Fernandez, Carmen
    Dominguez-Pimentel, Virginia
    Muros de Fuentes, Mercedes
    Gorriz, Jose L.
    Martinez-Castelao, Alberto
    Navarro-Gonzalez, Juan F.
    [J]. JOURNAL OF PHYSIOLOGY-LONDON, 2014, 592 (18): : 3997 - 4012
  • [7] Molecular Therapeutics for Diabetic Kidney Disease: An Update
    Guo, Man
    He, Fangfang
    Zhang, Chun
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (18)
  • [8] A NEW ERA OF CUSHING DISEASE THERAPEUTICS
    Fleseriu, M.
    McCartney, S.
    [J]. ACTA ENDOCRINOLOGICA-BUCHAREST, 2013, 9 (01) : 89 - 96
  • [9] New insights into the role of immunity and inflammation in diabetic kidney disease in the omics era
    Hu, Xinrong
    Chen, Sixiu
    Ye, Siyang
    Chen, Wei
    Zhou, Yi
    [J]. FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [10] Diabetic kidney diseases revisited: A new perspective for a new era
    Fu, Haiyan
    Liu, Silvia
    Bastacky, Sheldon I.
    Wang, Xiaojie
    Tian, Xiao-Jun
    Zhou, Dong
    [J]. MOLECULAR METABOLISM, 2019, 30 : 250 - 263
12345